01—Abstract
Summary
Summary of the 8-K filed January 23, 2025. Cited figures are marked; the original filing is the authoritative source.
MicroStrategy Incorporated (now Strategy Inc) filed this Form 8-K to report the results of its 2025 Special Meeting of Stockholders, held on January 21, 2025, and to disclose related charter and equity plan changes.
Stockholders approved an amendment to the Second Restated Certificate of Incorporation increasing authorized Class A common stock from 330,000,000 to 10,330,000,000 shares, and a separate amendment increasing authorized preferred stock from 5,000,000 to 1,005,000,000 shares. The Certificate of Amendment, which also raises total authorized capital stock from 500,000,000 to 11,500,000,000 shares, was filed with the Delaware Secretary of State on January 22, 2025 and became effective upon filing. Stockholders also approved an amendment to the MicroStrategy Incorporated 2023 Equity Incentive Plan, previously adopted by the Board on December 20, 2024, that provides newly appointed non-employee directors with automatic equity awards at appointment.
Each such director receives awards with an aggregate fair value of $2,000,000,a split evenly between non-statutory stock options and restricted stock units, vesting annually over four years. A fourth proposal, to adjourn the meeting, was approved but was unnecessary because a quorum and sufficient votes were present for the other three proposals.
For investors, the filing's most significant element is the sharp increase in authorized Class A common stock and preferred stock, which expands the company's capacity to issue shares in the future. The filing itself does not state the purpose of the increase or any planned issuance; the vote tallies show all three substantive proposals passed, with the Class A and preferred increases each receiving roughly 235 million votes for and about 38 million against.
02—Key points
Key Highlights
- Stockholders approved increasing authorized Class A common stock from 330,000,000 to 10,330,000,000 shares (234,937,922 for, 37,896,858 against, 356,581 abstentions).
- Stockholders approved increasing authorized preferred stock from 5,000,000 to 1,005,000,000 shares (234,572,276 for, 38,228,847 against, 390,238 abstentions).
- Total authorized capital stock rises from 500,000,000 to 11,500,000,000 shares; the Certificate of Amendment became effective upon Delaware filing on January 22, 2025.
- Stockholders approved the 2024 Plan Amendment to the 2023 Equity Incentive Plan, providing automatic equity grants to newly appointed non-employee directors (239,311,116 for, 32,991,507 against, 888,738 abstentions).
- Each newly appointed non-employee director receives equity awards with an aggregate fair value of $2,000,000, split equally between non-statutory stock options and restricted stock units vesting annually over four years.
- The adjournment proposal was approved, but adjournment was deemed unnecessary because a quorum and sufficient votes were present for Proposals 1 through 3.
- The Special Meeting was held on January 21, 2025, and the Board had adopted the plan amendment on December 20, 2024, subject to stockholder approval.
03—Questions
Frequently Asked Questions
What did stockholders vote to approve at the January 21, 2025 Special Meeting?
Stockholders approved three substantive proposals: increasing authorized Class A common stock to 10,330,000,000 shares, increasing authorized preferred stock to 1,005,000,000 shares, and amending the 2023 Equity Incentive Plan to provide automatic equity grants to newly appointed non-employee directors. An adjournment proposal was also approved but not needed.
How much did authorized capital stock increase?
Total authorized capital stock, the sum of Class A common stock, Class B common stock and preferred stock, increases from 500,000,000 to 11,500,000,000 shares. The Certificate of Amendment was filed with the Delaware Secretary of State on January 22, 2025 and became effective that day.
What equity compensation do new non-employee directors receive under the amended plan?
Beginning December 20, 2024, each newly appointed non-employee director automatically receives, on the date of appointment, equity awards with an aggregate fair value of $2,000,000. Half ($1,000,000) is a non-statutory stock option and half is restricted stock units, with each award vesting annually in equal installments over four years.
Did any proposal fail to pass?
The filing reports that all three substantive proposals, along with the adjournment proposal, were approved by the requisite votes. The votes against each proposal were substantially smaller than the votes for, and no broker non-votes were recorded.
Where can investors find more detail on the plan amendment?
A more detailed description of the 2024 Plan Amendment and the Amended Plan appears on pages 13 to 24 of the definitive proxy statement on Schedule 14A filed January 3, 2025, and the complete Amended Plan is included as Appendix D to that proxy statement. Both are incorporated by reference.
04—Continue